A5017724806- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Advanced X-ray and CT Imaging
- Surgical Simulation and Training
- Hematopoietic Stem Cell Transplantation
- Augmented Reality Applications
- MRI in cancer diagnosis
- Anatomy and Medical Technology
- Gallbladder and Bile Duct Disorders
Stanford University
2016-2018
Stanford Medicine
2016
Stanford Health Care
2016
Theodor Bilharz Research Institute
2016
Purpose To develop and validate a predictive model for postembolization syndrome (PES) following transarterial hepatic chemoembolization (TACE) hepatocellular carcinoma. Materials Methods In this single-center, retrospective study, 370 patients underwent 513 TACE procedures between October 2014 September 2016. Seventy percent of the were randomly assigned to training data set remaining 30% testing set. Variables included demographic, laboratory, clinical, procedural details. PES was defined...